[b] [b]9-14 December 2012[/b][/b]
[url="http://www.wellcome.ac.uk/Funding/Biomedical-science/Funded-projects/Major-initiatives/Wellcome-Trust-Sanger-Institute/index.htm"]Wellcome Trust Genome Campus[/url], Hinxton, Cambridge
[b]Application deadline extended to 28 September 2012[/b]
[b] [b]Course summary[/b][/b]
A joint initiative of the Wellcome Trust and the Royal College of Pathologists and aimed primarily at trainee pathologists or haematologists, this inaugural residential course aims to introduce participants to the rapidly evolving field of the molecular diagnosis of cancer.
Molecular techniques in current use, as well as the hurdles to the introduction of these new approaches into routine clinical practice, will be covered. In addition, the ethical, societal and practical implications of introducing genome-wide genetic analyses to the clinic will be considered.
The course will host a number of leading national and international speakers who will give lectures on the molecular pathology of a number of cancers, including lung, colorectal, leukaemia, myeloma and others.
[b]PLEASE NOTE: bursaries are available for clinical and academic applicants from anywhere in the world to attend this course, see below for details. In addition, CPD accreditation will be sought from the Royal College of Pathologists and the Royal College of Physicians.[/b]
[img]http://www.wellcome.ac.uk/stellent/images/CorporateRefocus/px.gif[/img]
[b] [b]Course programme[/b][/b]
Topics to be covered in lectures and practicals will include:[list]
[*]Standard and real-time PCR
[*]DNA electrophoresis
[*]Capillary (Sanger) sequencing
[*]Fluorescence in situ hybridisation (FISH)
[*]Karyotyping
[*]State-of-the-art next-generation sequencing technologies
[*]Target enrichment approaches
[*]Bioinformatic analysis for mutation detection
[/list]
It is anticipated that at the end of the course, participants will have an understanding of current and future molecular methodologies applied to cancer diagnosis and be able to participate in the impending revolution in the practice of clinical pathology and haematology. Additionally, the course hopes to inspire trainees to follow a career in genomic cancer medicine and research.
[img]http://www.wellcome.ac.uk/stellent/images/CorporateRefocus/px.gif[/img]
[b] [b]Course instructors[/b][/b]
George Vassiliou (Wellcome Trust Sanger Institute, Hinxton, UK)
Anthony Bench (Addenbrooke’s Hospital, Cambridge, UK)
Bridget Manasse (Addenbrooke’s Hospital, Cambridge, UK)
Harold Swerdlow (Wellcome Trust Sanger Institute, Hinxton, UK)
Peter Ellis (Wellcome Trust Sanger Institute, Hinxton, UK)
Michael Quail (Wellcome Trust Sanger Institute, Hinxton, UK)
Serena Nik-Zainal (Wellcome Trust Sanger Institute, Hinxton, UK)
Jeffrey Barrett (Wellcome Trust Sanger Institute, Hinxton, UK)
Elli Papaemmanuil (Wellcome Trust Sanger Institute, Hinxton, UK)
[b] [b]Guest speakers[/b][/b]
George Vassiliou (Wellcome Trust Sanger Institute, Hinxton, UK)
Mike Scott (Cambridge University Hospitals NHS Trust, UK)
Susanna Cooke (Wellcome Trust Sanger Institute, Hinxton, UK)
Manuel Salto-Tellez (Queen's University Belfast, UK)
David Gonzalez de Castro (The Institute of Cancer Research, UK)
Rachel Butler (Cardiff and Vale University Health Board, UK)
Mark Arends (University of Cambridge, UK)
Ian Cree (Warwick Medical School, UK)
Angela Douglas (Cheshire and Merseyside Genetics Laboratory, UK)
Niccolo Bolli (Wellcome Trust Sanger Institute, Hinxton, UK)
[b] [b]CPD Accreditation[/b][/b]
CPD accreditation for this course will be sought from the Royal College of Pathologists and the Royal College of Physicians.
For more information visit: www.wellcome.ac.uk/Education-resources/Courses-and-conferences/Advanced-Courses-and-Scientific-Conferences/Advanced-Courses/WTVM055392.htm
Event details
